Pharmaceutical entities challenge in the Supreme Court the exclusivity of hospitals in dispensing magistral formulas based on medicinal cannabis, as provided in a recent decree

Review of the standard may limit imports via RDC 660 if there is a national equivalent; director Thiago Campos presents his point of view

Scientific Committee maintains technical rigor and focuses on a forward-looking program in the 5th edition of the event in São Paulo

Bill under review in Delaware may allow the use of medical cannabis in hospitals by terminal patients, with specific safety and storage rules

"Tempo Bom" work combines science and Northeastern popular culture; project will raise funds to address the use of medical cannabis in Brazil

Patient follow-up for up to two years

Event opens deadline for submission of scientific abstracts in oral presentation and poster formats

Resumption of review by Anvisa and final deadline from STJ for cultivation define the sector's direction in the first quarter of the year

The Spanish Supreme Court has accepted the request from pharmaceutical entities challenging the exclusivity of dispensing cannabis products only in hospitals, as determined by the recent Royal Decree

CFO supports dentists among authorized professionals to prescribe safely and with quality

Ministry of Health extends deadline to avoid treatment interruptions in 2026; industry demands permanent law already validated by the EU

Agreement aims to address Burnout and chronic pain in employees of INSS and SPPREV through a partnership with a therapeutic association

The United Kingdom has published the first official guide to guide police action in the face of patients using prescribed medicinal cannabis

Companies report delays in shipments clearance, while official data from Anvisa indicate reduced average deadlines and a high approval rate

Associations question the exclusivity of dispensing in hospitals provided for in the new Royal Decree; deadline for defining clinical uses by the regulatory agency expired in early January

Ana Gabriela Batista demands, during industry congress, guidelines that facilitate treatments and ensure legal certainty

Bill on medicinal cannabis in Germany enters a decisive phase in Parliament and receives warnings from experts about regulatory and implementation challenges

A scientific review highlights the lack of robust evidence on medicinal cannabis and reinforces the need for more rigorous and balanced research in the field

In an interview with Deusa Cast, Beto Brant analyzes the role of patient associations and compares the medical cannabis models of Brazil and Uruguay

Meeting at the Planalto, with the presence of Eduardo Suplicy, discusses the recognition of associations and access to treatment